tiprankstipranks
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market

Zenas BioPharma, Inc. (ZBIO) Stock News & Sentiment

Compare
67 Followers
Zenas BioPharma’s Obexelimab: A Promising Therapy with a Buy Rating and $30 Price Target
Premium
Ratings
Zenas BioPharma’s Obexelimab: A Promising Therapy with a Buy Rating and $30 Price Target
4d ago
Zenas BioPharma, Inc. (ZBIO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Matthew Caufield from H.C. Wainwright reiterated a Buy rating on ...Read more

News Score - Last 7 Days

Neutral
ZBIO
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ZBIO’s Media Buzz Sentiment?
Currently, no data Available
What is ZBIO’s weekly average amount of articles?
Currently, no data Available
What is ZBIO’s News Sentiment?
50% of articles about ZBIO were positive this week, compared to its sector average of 55%.
    Healthcare Stocks that are Trending in the News
    CRLBFCresco Labs
    OPRXOptimizeRx
    CKPTCheckpoint Therapeutics
    CSBTFKuros Biosciences
    MDPediatrix Medical Group
    Showing the stocks with the most bullish news sentiment over the past week
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis